Nowadays millions of people die each year from cancer. It’s a medical professionals to save lives of patients worldwide.At the same time the future of cancer therapies is here now, several targeted or gene therapies are gaining trust, but their efficiency is strictly depends on proper and real time targeted tumor biology diagnostics, which doeas not exist yet. That’s why we’ve invented and developed inPROBE, a platform technology which links targeted therapies with targeted diagnostics.Our technology will reduce diagnosis time, increase precision and improve the effects of innovative cancer treatments. It can be used both in cancer diagnostics and therapies monitoring in real time and in a natural state, thus giving medical professionals a previously unavailable fast and efficient tool.
Key benefits
PERSONALIZED TARGETED POINT-OF-CARE DIAGNOSTICS
HELPING ONCOLOGISTS TO IDENTIFY THE RIGHT PATIENTS WHO
BENEFIT THE MOST FROM INNOVATIVE TARGETED TREATMENTS
PATIENTS WELLBEING
Less pain. No waiting time.
Immediate personalized targeted treatment introduction lowering high stress
HIGH SENSITIVITY
No tumor infraction benefiting
with no CANCER METASTASIS.
Enough to get close to the tumor with USG guidance
OBJECTIVE RESULTS
Numerical results No more false results
IN VIVO EXAMINATION AND REAL TIME RESULTS
No tissue biopsy
Results in minutes
NUMEROUS SCALE-UP POSSIBILITES
Most cancer biomarkers Real-time drug delivery in SITU monitoring Surgical oncology Infectious diseases and many others
How it works
inPROBEis a nano-size glass probe placed in vivo inside a very thin biopsy needle, connected to a detecting device and with innovative components on a probe tip.